Literature DB >> 22440150

Improving matrix metalloproteinase-2 specific response of a hydrogel system using electrophoresis.

Yu Zhang1, Richard A Gemeinhart.   

Abstract

Matrix metalloproteinases (MMPs) overexpression plays a critical role in cancer invasion and metastasis. We utilized this key feature of tumor microenvironment to develop a disease-stimuli triggered drug delivery system. Poly(acrylic acid) hydrogels were synthesized by UV polymerization and pendant MMP-2 sensitive peptides (Gly-Pro-Leu-Gly-Val-Arg-Gly-Lys) conjugated throughout using EDC/sulfo-NHS chemistry. There were significantly more peptides released in the presence of MMP-2 compared with the control groups. The released peptide fragments were analyzed by HPLC and MALDI-MS and confirmed to be the expected fragments. In order to avoid nonspecific release of nonconjugated (i.e. unreacted) peptides, a novel method of electrophoretic washing was developed disrupting the strong electrostatic interactions between the peptides and the pendant groups of the hydrogel. After electrophoresis, the nonspecific peptide release in the absence of MMP-2 was minimized. This newly developed purification system significantly improved the control of release to be in response of the magnitude of the stimuli, i.e. MMP. Specifically, peptides were released proportionally to the concentration of MMP-2 present. Now that many of the design parameters have been examined, anticancer drugs will be conjugated to the MMP sensitive peptide linkers with the goal of implantation in a tumor void releasing anticancer reagent in response to elevated level of MMPs.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440150      PMCID: PMC3327771          DOI: 10.1016/j.ijpharm.2012.03.012

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  32 in total

1.  A reversibly antigen-responsive hydrogel.

Authors:  T Miyata; N Asami; T Uragami
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

Review 2.  Production of recombinant protein therapeutics in cultivated mammalian cells.

Authors:  Florian M Wurm
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

3.  Enzyme responsive polymer hydrogel beads.

Authors:  Paul D Thornton; Gail McConnell; Rein V Ulijn
Journal:  Chem Commun (Camb)       Date:  2005-11-02       Impact factor: 6.222

4.  Binding and release of consensus peptides by poly(acrylic acid) microgels.

Authors:  Helena Bysell; Artur Schmidtchen; Martin Malmsten
Journal:  Biomacromolecules       Date:  2009-08-10       Impact factor: 6.988

5.  Matrix metalloprotease triggered delivery of cancer chemotherapeutics from hydrogel matrixes.

Authors:  Jovita R Tauro; Richard A Gemeinhart
Journal:  Bioconjug Chem       Date:  2005 Sep-Oct       Impact factor: 4.774

Review 6.  Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.

Authors:  S Zucker; M Hymowitz; C Conner; H M Zarrabi; A N Hurewitz; L Matrisian; D Boyd; G Nicolson; S Montana
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

7.  Metalloprotease-specific poly(ethylene glycol) methyl ether-peptide-doxorubicin conjugate for targeting anticancer drug delivery based on angiogenesis.

Authors:  M Bae; S Cho; J Song; G Y Lee; K Kim; J Yang; K Cho; S Y Kim; Y Byun
Journal:  Drugs Exp Clin Res       Date:  2003

8.  Controlled release of insulin from pH/temperature-sensitive injectable pentablock copolymer hydrogel.

Authors:  Dai Phu Huynh; Guang Jin Im; Su Young Chae; Kang Choon Lee; Doo Sung Lee
Journal:  J Control Release       Date:  2009-03-12       Impact factor: 9.776

9.  Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.

Authors:  Takeshi Terada; Mieko Iwai; Shigeru Kawakami; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  J Control Release       Date:  2006-02-20       Impact factor: 9.776

10.  In vitro evaluation of functional interaction of integrin alphavbeta3 and matrix metalloprotease-2.

Authors:  Deepali G Vartak; Bao-Shiang Lee; Richard A Gemeinhart
Journal:  Mol Pharm       Date:  2009 Nov-Dec       Impact factor: 4.939

View more
  4 in total

Review 1.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

2.  Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential.

Authors:  Yu Zhang; Melanie Köllmer; Jason S Buhrman; Mary Y Tang; Richard A Gemeinhart
Journal:  Peptides       Date:  2014-06-23       Impact factor: 3.750

3.  Proteolytically activated anti-bacterial hydrogel microspheres.

Authors:  Jason S Buhrman; Laura C Cook; Jamie E Rayahin; Michael J Federle; Richard A Gemeinhart
Journal:  J Control Release       Date:  2013-06-28       Impact factor: 9.776

4.  In-house preparation of hydrogels for batch affinity purification of glutathione S-transferase tagged recombinant proteins.

Authors:  Jason S Buhrman; Jamie E Rayahin; Melanie Köllmer; Richard A Gemeinhart
Journal:  BMC Biotechnol       Date:  2012-09-18       Impact factor: 2.563

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.